Clinical trial · Observational
Asprosın And Tumor Necrosıs Factor-α Levels In Type 2 Dıabetıc Chronıc Periodontitis
Evaluatıon Of Asprosın And Tumor Necrosıs Factor-α Levels In Gıngıval Crevıcular Fluıd And Serum Of Patıents Wıth Controlled And Uncontrolled Type 2 Dıabetıc Chronic Periodontitis
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Periodontal disease is a chronic, multifactorial inflammatory disease in which biochemical and cellular events trigger each other, leading to the destruction of the tissues supporting the teeth . The pathogenesis of the disease is a dynamic process that develops as a result of complex interactions between pathogenic bacteria and the host response . There is a bidirectional relationship between diabetes mellitus (DM), which is among the systemic diseases that negatively affect the host immune response, and periodontal disease. In the case of DM, long-term hyperglycemia causes proteins to react irreversibly with glucose, resulting in the formation of advanced glycation end products (AGEs). It is suggested that increased AGE levels increase cytokine secretion against periodontopathogens, exacerbate inflammatory tissue destruction, and may negatively affect biological functions through cell-cell and cell-matrix interactions in the connective tissue. The present study was conducted to gain further insight into the role of CGF and serum Asprosin level in the pathogenetic processes linking DM and periodontal disease.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Periodontal Diseases | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Gingival Crevicular Fluid | Other | — | UNRESOLVED |
| Serum Asprosin | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (4)
- label
- Control Group: systemically and periodontally healthy control group
- description
- Periodontal clinical parameters and examination of asprosin levels in gingival crevicular fluid and serum samples
- interventionNames
- Other: Gingival Crevicular Fluid
- Diagnostic Test: Serum Asprosin
- label
- Uncontrolled T2DM-CP: Stage III Grade C Periodontitis, Uncontrolled T2DM group
- description
- Periodontal clinical parameters and examination of asprosin levels in gingival crevicular fluid and serum samples
- interventionNames
- Other: Gingival Crevicular Fluid
- Diagnostic Test: Serum Asprosin
- label
- Controlled T2DM-CP: Stage III Grade B Periodontitis, Controlled T2DM
- description
- Periodontal clinical parameters and examination of asprosin levels in gingival crevicular fluid and serum samples
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * The patient must be a volunteer Exclusion Criteria: \-
References
Publications (0)
Data not yet available